WCN26-4096 COMPARISON OF FOUR DIFFERENT GENTAMICIN DOSING GUIDELINES FOR PEDIATRIC PATIENTS: VIRTUAL POPULATION INSIGHTS

Read full text Summarise with VIRAT
Authors: Rasha Hamed Hussein, Felix J. Meigel, Ana Catalina Álvarez-Elías, Doris Helene Fuertinger
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Gentamicin is the recommended aminoglycoside for empirical treatment of serious neonatal and pediatric infections. Optimal therapy requires achieving high peak concentrations to maximize antibacterial efficacy while maintaining low trough levels to prevent oto- and nephrotoxicity. However, the ongoing maturation of renal function introduces substantial pharmacokinetic variability across pediatric age groups. Despite notable differences among national dosing guidelines, it remains uncertain whether these regimens ensure both effective and safe therapy across all ages.

Fields of Study & Subjects

Antibiotics Pharmacokinetics and Efficacy Pharmaceutical studies and practices Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103965–103965
Publication date
25 March 2026
Language
EN